Vaccine maker AstraZeneca pauses late stage studies

91
66.7%
Published on 9 Sep 2020, 11:17
Late-stage studies of AstraZeneca’s COVID-19 vaccine candidate are on temporary hold while the company investigates whether a recipient’s “potentially unexplained” illness is a side effect of the shot.
newstechmusickids